Sorry, you need to enable JavaScript to visit this website.

ELLENCE® (epirubicin HCl) Indications and Usage

1 INDICATIONS AND USAGE

ELLENCE is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer [see Clinical Studies (14.1)].

What's New

No Current Announcements.

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Search

Please enter your search term(s) for ELLENCE®